Table 1 Demographics and co-infections at baseline
Characteristics | ||
|---|---|---|
MSM, n (%) | 131 (100) | |
Age (years), median (IQR) | 47 (39–52) | |
Race, n (%) | White | 84 (64.1) |
Black | 41 (31.3) | |
Other | 6 (4.6) | |
Hispanic Ethnicity, (n, %) | 43 (32.8) | |
HIV RNA <50 copies/ml, n (%) | 110 (84.0) | |
≥90 % ART adherence past 4 weeks, n (%) | 115 (87.8) | |
CD4+ T-cell counts/μL, median (IQR) | 604 (414–761) | |
Unprotected anal sex acts past 4 weeks, median (IQR) | 0 (0–2) | |
Any drug use, n (%) | 46 (35.9) | |
Median Number Male Sexual Partners past 4 weeks, median (IQR) | 3 (1–6) | |
High Risk HPV mRNA at baseline, n (%) | ||
Semen (n = 98) | 7 (7.1) | |
Anal (n = 120) | 54 (45.0) | |
Throat (n = 127) | 5 (3.9) | |
Herpeviruses Shedding, n (%) | ||
Any detectable HHV DNA | 83 (63.7) | |
Any detectable HSV (1 or 2) DNA | 3 (2.3) | |
Any detectable CMV DNA | 69 (52.7) | |
Any detectable EBV DNA | 36 (27.5) | |
Any detectable HHV-6 DNA | 9 (6.9) | |
Any detectable HHV-7 DNA | 10 (8.8) | |
Any detectable HHV-8 DNA | 3 (2.3) | |